{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:37:15Z","timestamp":1783942635563,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ajoc.2022.101788","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T20:20:27Z","timestamp":1672345227000},"page":"101788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-8053","authenticated-orcid":false,"given":"Takao","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Toriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Hoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-5032","authenticated-orcid":false,"given":"Toshinori","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2022.101788_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ophtha.2020.06.028","article-title":"HAWK and HARRIER: ninety-six-week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration","volume":"128","author":"Dugel","year":"2021","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101788_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/a-1101-9126","article-title":"A randomized, double-masked, multicenter, phase III study assessing the efficacy and safety of brolucizumab versus aflibercept in patients with visual impairment due to diabetic macular edema (KITE)","volume":"237","author":"Garweg","year":"2020","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ajoc.2022.101788_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajo.2022.01.004","article-title":"KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema","volume":"238","author":"Brown","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101788_bib4","article-title":"Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration","volume":"18","author":"Haug","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajoc.2022.101788_bib5","article-title":"Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations","volume":"18","author":"Jain","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"12","key":"10.1016\/j.ajoc.2022.101788_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259879","article-title":"Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration","volume":"16","author":"Mukai","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101788_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10384-021-00818-8","article-title":"Three cases of brolucizumab-associated retinal vasculitis treated with systemic and local steroid therapy","volume":"65","author":"Kataoka","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101788_bib8","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ophtha.2015.12.030","article-title":"Single-chain antibody fragment VEGF inhibitor RTH258 for neovascular age-related macular degeneration: a randomized controlled study","volume":"123","author":"Holz","year":"2016","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajoc.2022.101788_bib9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ophtha.2020.11.011","article-title":"Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with brolucizumab: post hoc review of HAWK and HARRIER","volume":"128","author":"Mones","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101788_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.survophthal.2010.08.006","article-title":"Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease","volume":"56","author":"Tolentino","year":"2011","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101788_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","article-title":"Association of vitreous inflammatory factors with diabetic macular edema","volume":"116","author":"Funatsu","year":"2009","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101788_bib12","doi-asserted-by":"crossref","first-page":"9380","DOI":"10.1038\/s41598-018-27536-5","article-title":"Distinct retinal capillary plexuses in normal eyes as observed in optical coherence tomography angiography axial profile analysis","volume":"8","author":"Hirano","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101788_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.oret.2021.08.010","article-title":"Early recovery from vasculitis after brolucizumab with prompt steroid treatment","volume":"6","author":"Iesato","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101788_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s10384-021-00819-7","article-title":"Three Japanese cases of intraocular inflammation after intravitreal brolucizumab injections in one clinic","volume":"65","author":"Hikichi","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.ajoc.2022.101788_bib15","first-page":"S11","article-title":"2. Classification and diagnosis of diabetes","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ajoc.2022.101788_bib16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00417-009-1147-x","article-title":"Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy","volume":"247","author":"Shimura","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622005345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622005345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:09:07Z","timestamp":1752980947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993622005345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":16,"alternative-id":["S2451993622005345"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101788","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101788"}}